Malathion
Back to searchMolecule Structure
Scientific Name
Malathion
Description of the Drug
Malathion is a parasympathomimetic organophosphate used to treat head lice.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00772
http://www.drugbank.ca/drugs/DB00772
Brand Name(s)
Cythion, Derbac-m, Malathion, Organoderm, Ovide, Prioderm, Quellada-m, Suleo-m
Company Owner(s)
Suven Pharmaceuticals Ltd, Mylan Pharmaceuticals Inc, Taro Pharmaceutical Industries Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Acetylcholinesterase | SINGLE PROTEIN | INHIBITOR | CHEMBL2362988 |
Clinical Trial(s)
Unichem Links
| Atlas | Malathion | |
| SureChEMBL | SCHEMBL27358 | |
| PharmGKB | PA164748092 | |
| Human Metabolome Database | HMDB0014910 | |
| DrugBank | DB00772 | |
| PubChem: Thomson Pharma | 14895285 | |
| PubChem | 4004 | |
| NMRShiftDB | 20209207 | |
| Nikkaji | J381F | |
| BindingDB | 85372 | |
| EPA CompTox Dashboard | DTXSID4020791 | |
| DrugCentral | 1626 | |
| Brenda | 147039 | 1888 |
| rxnorm | OVIDE | MALATHION |
| KEGG Ligand | C07497 | |
| ChEBI | 141474 |
